A US study shows a sharp rise in prolonged emergency department stays and boarding times for older US adults, particularly in ...

The FDA has approved Zegfrovy (sunvozertinib) for locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.

Doing a certain amount of exercise is linked to a 30% to 40% lower risk of an early death from any cause, according to a new ...